RA'ANANA, Israel, April 29, 2014 /PRNewswire/ -- SMART Medical Systems Ltd., a developer and manufacturer of advanced endoscopy and colonoscopy products for gastrointestinal (GI) medicine, announced the appointment of Mr. Harald Beyer as Senior Director of Global Strategy. Mr. Beyer's engagement with SMART comes in addition to his Executive role at SORING GmbH, a global surgical devices company.
Gadi Terliuc, CEO of SMART Medical systems said, "Mr. Beyer's unique professional skills and expertise, as well as his valuable experience and connections in the endoscopy field, will substantially contribute to SMART's global position in the endoscopy market as we advance G-EYE™ and NaviAid™ in Europe, China and the United States."
"In the field of GI, SMART operates one of the most important and promising platforms, with the potential to become the new standard of care in colonoscopy and GI endoscopy," said Mr. Beyer. "SMART's product platform can be deployed in the global markets through a variety of business models and partnerships and provides a wide span of commercialization opportunities."
Mr. Beyer's experience and executive management career within the gastroenterology and endoscopy fields spans more than 20 years. Previously, Mr. Beyer served for 10 years at Pentax Medical, a global leader in endoscopic imaging, as Vice President of Sales and Strategic Initiatives and as General Manager, Life Care of Pentax Europe. Prior to joining Pentax Medical, Mr. Beyer led the European operations of Given Imaging, a world leader in capsule endoscopy. Throughout his career, Mr. Beyer has lead effective implementation of new and innovative endoscopy products within diverse markets, which have made a profound impact on the endoscopic industry.
About SMART Medical Systems
SMART Medical Systems is a pioneer in the development and manufacture of innovative medical devices in the field of gastro-intestinal (GI) endoscopy. Its proprietary technology enhances the performance and capabilities of existing endoscopy equipment, in an intuitive and cost-effective manner. SMART's CE-marked and FDA-cleared NaviAid™ product family is commercially distributed in key global markets. Its G-EYE™ product (CE marked, not yet FDA cleared) is presently under commercialization in selected regions. SMART is headquartered in Israel and operates in the United States through its wholly owned subsidiary, SMART GI Inc., and in Greater China through its Hong Kong subsidiary, Medico HK Limited. For more information, please visit: www.smartmedsys.com.
SOURCE SMART Medical Systems Ltd.